Presentation delivered by Dr Dr Ala Alwan, WHO Regional Director for the Eastern Mediterranean at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean
The document summarizes information from a session of the Regional Committee for the Eastern Mediterranean regarding tobacco control efforts. It notes that tobacco kills over 7 million people every year globally and discusses the goal of a 30% reduction in tobacco use by 2025 in the Eastern Mediterranean region. It provides data on current tobacco use prevalence rates in the region and projections for 2025. It also reviews the status of implementing various tobacco control policies based on the WHO FCTC and evidence that fully implementing these policies at the highest level could reduce tobacco use prevalence by 20-40% within 5 years based on modeling studies. The document encourages countries to move forward with adopting the maximum level of all tobacco control policies.
This document summarizes resolutions and decisions from various World Health Assembly and Executive Board meetings that are of regional concern. Key topics discussed include strategies for HIV, viral hepatitis, STIs, food safety, epilepsy, non-communicable diseases, harmful use of alcohol, social determinants of health, and sustainable financing. The regional office will support member states in implementing frameworks, strategies, and plans on these issues through regional consultations, capacity building, and technical guidance. Progress on non-communicable diseases and neurological disorders in particular falls short of targets in most member states in the region.
This document outlines WHO's process for developing a global strategy on health, environment, and climate change (HECC). It provides background on the high disease burden from environmental risks. It discusses the opportunity presented by the 2030 Agenda for Sustainable Development and WHO's general program of work. The vision is for environments that eliminate nearly 1/4 of disease burden through prevention and healthy choices. Key strategy elements include scaling prevention, cross-sectoral action, strengthening health sectors, and building support. Regional implications and WHO's contributions are also summarized. Feedback is requested on the draft strategy.
The document discusses updates to the WHO's Thirteenth General Programme of Work results framework. It outlines four strategic objectives: create an enabling environment, increase financial investments, promote data sharing, and ensure equitable access to research benefits. It describes the balanced scorecard approach to assess performance across six dimensions. Country case studies will demonstrate achievements and lessons learned in reaching triple billion targets of universal health coverage, emergency preparedness, and healthier populations. The results framework will be refined through regional committee consultations in 2019.
Presented by Piroska Östlin, Director and Åsa Nihlén, Technical Officer, Division of Policy and Governance for Health and Well-being, WHO/Europe, at the 66th session of the WHO Regional Committee for Europe.
This document outlines the need for and challenges of implementing integrated disease surveillance across the Eastern Mediterranean region to overcome data fragmentation. It recommends establishing governance and coordination between countries, reducing inefficiencies through resource pooling, and operationalizing integrated disease surveillance through standardized procedures, training, and use of new technologies with timelines for implementation and support from WHO. Success stories from Egypt, UAE, and Pakistan demonstrate progress toward integration at the national level.
The document summarizes information from a session of the Regional Committee for the Eastern Mediterranean regarding tobacco control efforts. It notes that tobacco kills over 7 million people every year globally and discusses the goal of a 30% reduction in tobacco use by 2025 in the Eastern Mediterranean region. It provides data on current tobacco use prevalence rates in the region and projections for 2025. It also reviews the status of implementing various tobacco control policies based on the WHO FCTC and evidence that fully implementing these policies at the highest level could reduce tobacco use prevalence by 20-40% within 5 years based on modeling studies. The document encourages countries to move forward with adopting the maximum level of all tobacco control policies.
This document summarizes resolutions and decisions from various World Health Assembly and Executive Board meetings that are of regional concern. Key topics discussed include strategies for HIV, viral hepatitis, STIs, food safety, epilepsy, non-communicable diseases, harmful use of alcohol, social determinants of health, and sustainable financing. The regional office will support member states in implementing frameworks, strategies, and plans on these issues through regional consultations, capacity building, and technical guidance. Progress on non-communicable diseases and neurological disorders in particular falls short of targets in most member states in the region.
This document outlines WHO's process for developing a global strategy on health, environment, and climate change (HECC). It provides background on the high disease burden from environmental risks. It discusses the opportunity presented by the 2030 Agenda for Sustainable Development and WHO's general program of work. The vision is for environments that eliminate nearly 1/4 of disease burden through prevention and healthy choices. Key strategy elements include scaling prevention, cross-sectoral action, strengthening health sectors, and building support. Regional implications and WHO's contributions are also summarized. Feedback is requested on the draft strategy.
The document discusses updates to the WHO's Thirteenth General Programme of Work results framework. It outlines four strategic objectives: create an enabling environment, increase financial investments, promote data sharing, and ensure equitable access to research benefits. It describes the balanced scorecard approach to assess performance across six dimensions. Country case studies will demonstrate achievements and lessons learned in reaching triple billion targets of universal health coverage, emergency preparedness, and healthier populations. The results framework will be refined through regional committee consultations in 2019.
Presented by Piroska Östlin, Director and Åsa Nihlén, Technical Officer, Division of Policy and Governance for Health and Well-being, WHO/Europe, at the 66th session of the WHO Regional Committee for Europe.
This document outlines the need for and challenges of implementing integrated disease surveillance across the Eastern Mediterranean region to overcome data fragmentation. It recommends establishing governance and coordination between countries, reducing inefficiencies through resource pooling, and operationalizing integrated disease surveillance through standardized procedures, training, and use of new technologies with timelines for implementation and support from WHO. Success stories from Egypt, UAE, and Pakistan demonstrate progress toward integration at the national level.
Progress in and priorities for implementing the regional plans for the health sector response to HIV and hepatitis, Dr Masoud Dara, Acting Director, Communicable Diseases Department (69th session of the WHO Regional Committee for Europe)
Diabetes is a major public health issue in the Eastern Mediterranean region, with prevalence increasing significantly. By 2045, over 108 million people in the region are projected to have diabetes if no action is taken. Diabetes leads to high mortality and economic costs, with the annual burden in the region estimated at $60 billion. While some countries have policies and guidelines for diabetes management, services have been disrupted by COVID-19 and care is not fully included in pandemic response plans. A proposed regional framework outlines governance, management, prevention and surveillance strategies to guide country-level action from 2021-2030.
Presentation delivered by Dr Nadia Teleb, Regional Adviser, Vaccine Preventable Diseases at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean
The document discusses the development of the WHO's 13th General Programme of Work (GPW13) Results Framework for measuring impact. It provides an update on progress, including developing 46 outcome indicators and milestones aligned with the six GPW13 themes. It outlines next steps in finalizing the framework through additional member state consultations, establishing baselines and milestones, and reporting to the Executive Board and World Health Assembly. The goal is to obtain joint commitment for implementing the framework to measure GPW13 progress and impact.
This document summarizes the COVID-19 situation globally and in the Eastern Mediterranean region as of October 2020. It discusses key factors impacting COVID-19 transmission in the region like migrant workers, travel restrictions, fragility and conflict, mass gatherings, and demographics. It outlines achievements in expanding testing capacity, building on existing systems, and logistics support. It also notes challenges around IPC practices, lack of national programs, limited public health measures, and difficulty sustaining behavior changes. The document requests that ministers prioritize COVID-19 response, invest in health systems and preparedness, and engage all relevant sectors. It provides three recommendations for member states around implementing multi-sectoral plans, providing evidence-based public information,
Diabetes is a major public health issue in the Eastern Mediterranean region, with prevalence increasing significantly. By 2045, over 108 million people in the region are projected to have diabetes if no action is taken. Diabetes leads to suffering and complications and imposes a high economic burden. While some countries have policies and programs to address diabetes, prevention, management and care are still lacking. The WHO is proposing a new regional framework and emergency response strategies to help countries strengthen their diabetes prevention, control and care efforts from 2021-2030.
This document discusses the work of the WHO European Region's Division of Information, Evidence, Research and Innovation (DIR). It outlines DIR's role in providing guidance on health information activities, establishing the European Health Information Initiative (EHII) network, and their goal of an integrated health information system for Europe. It also summarizes DIR's work supporting countries' health information systems and capacities, and monitoring progress toward Health 2020 targets.
This document discusses challenges faced during the COVID-19 pandemic, including health workforce gaps, limited health system capacity, and lack of access to healthcare facilities and resources. It outlines WHO strategic priorities to promote healthier populations through universal health coverage and addressing health emergencies. Specific priorities include expanding immunization coverage, strengthening health workforces, and protecting populations from disease outbreaks. The challenges of the pandemic, as well as opportunities to build more resilient and equitable health systems, are also summarized.
1) The Eastern Mediterranean Region is the last region still endemic for wild poliovirus. It is facing outbreaks of circulating vaccine-derived poliovirus from within the region and neighboring areas.
2) The COVID-19 pandemic has significantly disrupted polio eradication activities in the region, with 4 months of paused vaccination campaigns resulting in 50 million missed children. New opportunities have also emerged from lessons learned with COVID-19.
3) Major ongoing circulating vaccine-derived poliovirus outbreaks require response campaigns in Somalia, Sudan, and Yemen. A novel oral poliovirus vaccine may be used in the region to help control outbreaks. Strengthening surveillance and expanding access across the region are priorities to
The document outlines an action plan for the health sector response to HIV in Europe with the vision of ending the AIDS epidemic as a public health threat by 2030. It identifies five strategic directions: (1) using data to guide focused services, (2) prioritizing prevention and treatment interventions, (3) delivering equitable services based on human rights, (4) financing a sustainable response, and (5) stimulating innovation. Fast-track actions are outlined under each strategic direction to strengthen coordination, expand testing and treatment, eliminate transmission, and transition to domestic financing. The draft resolution calls on countries to review strategies, strengthen prevention, ensure commitment and financing, and monitor implementation of the plan.
Health literacy in the WHO European Region, Dr Bente Mikkelsen, Director, Noncommunicable Diseases and Promoting Health through the Life-course / Kristina Mauer-Stender, Acting Director, Information, Evidence, Research and innovation (WHO Regional Office for Europe)
Prime Minister Modi chaired a meeting to ensure COVID-19 response activities are implemented. As of April 5th, India had reported 3,577 confirmed cases across 29 states, resulting in 83 deaths. The WHO is working closely with India's health ministry to strengthen surveillance and testing. The World Bank approved $1 billion to help India prevent, detect, and respond to the pandemic.
The document discusses the WHO Regional Director for the Eastern Mediterranean's annual report which covers topics such as:
- The Delta variant being twice as infectious as the original COVID-19 strain.
- Risks of reinfection even after initially being infected with the Delta variant.
- Noncommunicable diseases (NCDs) such as diabetes reaching epidemic levels in the region.
- The WHO's regional response to COVID-19 including laboratory testing, vaccine deliveries through Dubai, and support to countries.
- Progress on health-related UN Sustainable Development Goals and challenges in the region.
This document discusses ensuring continuity of essential health services during the COVID-19 pandemic, which is a critical priority. It outlines the impact of the pandemic on essential health services, including disruptions to services for noncommunicable diseases and declines in immunization rates. It also discusses challenges delivered essential health services during the pandemic, such as limitations in health system capacity and shortages of supplies. The document provides an overview of WHO's guidance and activities to support delivering essential health services during COVID-19, and innovative approaches that have been used. It calls for renewed commitment to achieving universal health coverage and the Sustainable Development Goals.
The document discusses accelerating primary health care strengthening in line with the Declaration of Astana. It outlines key global developments including the adoption of the Declaration of Astana in 2018 and commitments made by UN agencies to develop a Global Action Plan. The WHO's 13th General Programme of Work also began in 2019. 10 evidence-based policy accelerators are presented to advance primary health care, including establishing multi-profile teams, adopting population health management, and integrating health and social care. The WHO European Centre for Primary Health Care in Almaty will lead efforts to adapt frameworks to the European Region and ensure alignment with the policy accelerators.
Presented at the 66th session of the WHO Regional Committee for Europe by Dr Claudia Stein, Director,
Information, Evidence, Research and Innovation, WHO/Europe
Strategic directions for the health sector response to viral hepatitis include:
1) Improving surveillance and estimates of disease burden to focus action.
2) Defining essential intervention packages and setting national targets for coverage.
3) Addressing barriers like stigma to make hepatitis services accessible for all populations.
4) Building political commitment and innovative funding approaches for sustainable financing.
5) Prioritizing hepatitis research and rapidly translating findings into practice.
The action plan aims to halt transmission of hepatitis and ensure treatment access for all by 2030.
1) The document discusses the importance of digitalizing health systems in the Eastern Mediterranean region to improve health services and pandemic response.
2) It outlines key benefits of digital health such as better access to care, more efficient systems, and cost savings.
3) The document proposes following the Global Strategy for Digital Health (GSDH) by developing national digital health strategies, assessing countries' digital maturity levels, and collaborating with stakeholders on initiatives like a dynamic digital health maturity model.
NCD Planning: Current Stats and Opportunities for StrokeFeisul Mustapha
The document discusses non-communicable diseases (NCDs) planning in Malaysia and opportunities for stroke prevention. It summarizes the 2014 UN General Assembly outcome document on NCDs which outlines national commitments and global assignments between 2014-2018. These include setting national NCD targets and developing multisectoral policies and plans. It also discusses Malaysia's national strategic plan for NCDs from 2010-2014 and efforts to strengthen chronic disease management at the primary care level through multidisciplinary care teams and clinical practice guidelines. Availability of essential medicines for NCDs and lessons learned from working with other sectors are also covered.
Progress in and priorities for implementing the regional plans for the health sector response to HIV and hepatitis, Dr Masoud Dara, Acting Director, Communicable Diseases Department (69th session of the WHO Regional Committee for Europe)
Diabetes is a major public health issue in the Eastern Mediterranean region, with prevalence increasing significantly. By 2045, over 108 million people in the region are projected to have diabetes if no action is taken. Diabetes leads to high mortality and economic costs, with the annual burden in the region estimated at $60 billion. While some countries have policies and guidelines for diabetes management, services have been disrupted by COVID-19 and care is not fully included in pandemic response plans. A proposed regional framework outlines governance, management, prevention and surveillance strategies to guide country-level action from 2021-2030.
Presentation delivered by Dr Nadia Teleb, Regional Adviser, Vaccine Preventable Diseases at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean
The document discusses the development of the WHO's 13th General Programme of Work (GPW13) Results Framework for measuring impact. It provides an update on progress, including developing 46 outcome indicators and milestones aligned with the six GPW13 themes. It outlines next steps in finalizing the framework through additional member state consultations, establishing baselines and milestones, and reporting to the Executive Board and World Health Assembly. The goal is to obtain joint commitment for implementing the framework to measure GPW13 progress and impact.
This document summarizes the COVID-19 situation globally and in the Eastern Mediterranean region as of October 2020. It discusses key factors impacting COVID-19 transmission in the region like migrant workers, travel restrictions, fragility and conflict, mass gatherings, and demographics. It outlines achievements in expanding testing capacity, building on existing systems, and logistics support. It also notes challenges around IPC practices, lack of national programs, limited public health measures, and difficulty sustaining behavior changes. The document requests that ministers prioritize COVID-19 response, invest in health systems and preparedness, and engage all relevant sectors. It provides three recommendations for member states around implementing multi-sectoral plans, providing evidence-based public information,
Diabetes is a major public health issue in the Eastern Mediterranean region, with prevalence increasing significantly. By 2045, over 108 million people in the region are projected to have diabetes if no action is taken. Diabetes leads to suffering and complications and imposes a high economic burden. While some countries have policies and programs to address diabetes, prevention, management and care are still lacking. The WHO is proposing a new regional framework and emergency response strategies to help countries strengthen their diabetes prevention, control and care efforts from 2021-2030.
This document discusses the work of the WHO European Region's Division of Information, Evidence, Research and Innovation (DIR). It outlines DIR's role in providing guidance on health information activities, establishing the European Health Information Initiative (EHII) network, and their goal of an integrated health information system for Europe. It also summarizes DIR's work supporting countries' health information systems and capacities, and monitoring progress toward Health 2020 targets.
This document discusses challenges faced during the COVID-19 pandemic, including health workforce gaps, limited health system capacity, and lack of access to healthcare facilities and resources. It outlines WHO strategic priorities to promote healthier populations through universal health coverage and addressing health emergencies. Specific priorities include expanding immunization coverage, strengthening health workforces, and protecting populations from disease outbreaks. The challenges of the pandemic, as well as opportunities to build more resilient and equitable health systems, are also summarized.
1) The Eastern Mediterranean Region is the last region still endemic for wild poliovirus. It is facing outbreaks of circulating vaccine-derived poliovirus from within the region and neighboring areas.
2) The COVID-19 pandemic has significantly disrupted polio eradication activities in the region, with 4 months of paused vaccination campaigns resulting in 50 million missed children. New opportunities have also emerged from lessons learned with COVID-19.
3) Major ongoing circulating vaccine-derived poliovirus outbreaks require response campaigns in Somalia, Sudan, and Yemen. A novel oral poliovirus vaccine may be used in the region to help control outbreaks. Strengthening surveillance and expanding access across the region are priorities to
The document outlines an action plan for the health sector response to HIV in Europe with the vision of ending the AIDS epidemic as a public health threat by 2030. It identifies five strategic directions: (1) using data to guide focused services, (2) prioritizing prevention and treatment interventions, (3) delivering equitable services based on human rights, (4) financing a sustainable response, and (5) stimulating innovation. Fast-track actions are outlined under each strategic direction to strengthen coordination, expand testing and treatment, eliminate transmission, and transition to domestic financing. The draft resolution calls on countries to review strategies, strengthen prevention, ensure commitment and financing, and monitor implementation of the plan.
Health literacy in the WHO European Region, Dr Bente Mikkelsen, Director, Noncommunicable Diseases and Promoting Health through the Life-course / Kristina Mauer-Stender, Acting Director, Information, Evidence, Research and innovation (WHO Regional Office for Europe)
Prime Minister Modi chaired a meeting to ensure COVID-19 response activities are implemented. As of April 5th, India had reported 3,577 confirmed cases across 29 states, resulting in 83 deaths. The WHO is working closely with India's health ministry to strengthen surveillance and testing. The World Bank approved $1 billion to help India prevent, detect, and respond to the pandemic.
The document discusses the WHO Regional Director for the Eastern Mediterranean's annual report which covers topics such as:
- The Delta variant being twice as infectious as the original COVID-19 strain.
- Risks of reinfection even after initially being infected with the Delta variant.
- Noncommunicable diseases (NCDs) such as diabetes reaching epidemic levels in the region.
- The WHO's regional response to COVID-19 including laboratory testing, vaccine deliveries through Dubai, and support to countries.
- Progress on health-related UN Sustainable Development Goals and challenges in the region.
This document discusses ensuring continuity of essential health services during the COVID-19 pandemic, which is a critical priority. It outlines the impact of the pandemic on essential health services, including disruptions to services for noncommunicable diseases and declines in immunization rates. It also discusses challenges delivered essential health services during the pandemic, such as limitations in health system capacity and shortages of supplies. The document provides an overview of WHO's guidance and activities to support delivering essential health services during COVID-19, and innovative approaches that have been used. It calls for renewed commitment to achieving universal health coverage and the Sustainable Development Goals.
The document discusses accelerating primary health care strengthening in line with the Declaration of Astana. It outlines key global developments including the adoption of the Declaration of Astana in 2018 and commitments made by UN agencies to develop a Global Action Plan. The WHO's 13th General Programme of Work also began in 2019. 10 evidence-based policy accelerators are presented to advance primary health care, including establishing multi-profile teams, adopting population health management, and integrating health and social care. The WHO European Centre for Primary Health Care in Almaty will lead efforts to adapt frameworks to the European Region and ensure alignment with the policy accelerators.
Presented at the 66th session of the WHO Regional Committee for Europe by Dr Claudia Stein, Director,
Information, Evidence, Research and Innovation, WHO/Europe
Strategic directions for the health sector response to viral hepatitis include:
1) Improving surveillance and estimates of disease burden to focus action.
2) Defining essential intervention packages and setting national targets for coverage.
3) Addressing barriers like stigma to make hepatitis services accessible for all populations.
4) Building political commitment and innovative funding approaches for sustainable financing.
5) Prioritizing hepatitis research and rapidly translating findings into practice.
The action plan aims to halt transmission of hepatitis and ensure treatment access for all by 2030.
1) The document discusses the importance of digitalizing health systems in the Eastern Mediterranean region to improve health services and pandemic response.
2) It outlines key benefits of digital health such as better access to care, more efficient systems, and cost savings.
3) The document proposes following the Global Strategy for Digital Health (GSDH) by developing national digital health strategies, assessing countries' digital maturity levels, and collaborating with stakeholders on initiatives like a dynamic digital health maturity model.
NCD Planning: Current Stats and Opportunities for StrokeFeisul Mustapha
The document discusses non-communicable diseases (NCDs) planning in Malaysia and opportunities for stroke prevention. It summarizes the 2014 UN General Assembly outcome document on NCDs which outlines national commitments and global assignments between 2014-2018. These include setting national NCD targets and developing multisectoral policies and plans. It also discusses Malaysia's national strategic plan for NCDs from 2010-2014 and efforts to strengthen chronic disease management at the primary care level through multidisciplinary care teams and clinical practice guidelines. Availability of essential medicines for NCDs and lessons learned from working with other sectors are also covered.
Non-Communicable Diseases: Malaysia in Global Public HealthFeisul Mustapha
Paper presented at a CME Session, held in conjunction with the NIH Research Week 2014, 26 November 2014 at the Institute for Health Management, Bangsar
Next Step 2014 presentation by Dr. Timothy Armstrong from World Health Organi...Maidan.in
The document discusses non-communicable diseases (NCDs) and the World Health Organization's (WHO) efforts to address them. It notes that NCDs now account for a large share of premature deaths globally. The WHO aims to reduce the burden of NCDs through its 2013-2020 Global Action Plan, which includes objectives like strengthening national capacity and multisectoral partnerships. A key part of prevention is increasing physical activity, as the lack thereof is a major risk factor for NCDs like heart disease and diabetes. The WHO has issued recommendations on physical activity and partners with other organizations to promote initiatives that get people more involved in sports.
Ueda2016 the agenda for ncd prevention and control - samer jabbourueda2015
This document discusses non-communicable diseases (NCDs) in the Eastern Mediterranean region. It finds that NCDs account for over half of all deaths in the region. The top four NCDs - cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes - cause over 2.2 million deaths annually. The document then outlines the WHO's agenda and framework for NCD prevention and control. This includes strategic interventions related to governance, prevention, surveillance, and healthcare. It emphasizes that both population-level prevention efforts and improved healthcare services will be needed to achieve global NCD reduction targets.
Presented by Oleg Chestnov, Assistant Director-General for Noncommunicable Diseases and Mental Health, WHO, at the 64th session of the WHO Regional Committee for Europe.
Scope: The action plan provides a road map and a menu of policy options for all Member States and other stakeholders, to take coordinated and coherent action, at all levels, local to global, to attain the nine voluntary global targets, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by 2025.
Focus: The main focus of this action plan is on four types of NCDs — cardiovascular diseases, cancer, chronic respiratory diseases and diabetes — which make the largest contribution to morbidity and mortality due to NCDs, and on four shared behavioral risk factors — tobacco use, unhealthy diet, physical inactivity and harmful use of alcohol. It recognizes that the conditions in which people live and work and their lifestyles influence their health and quality of life.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe at the Meeting of the ministers of health of the SEEHN Member States (22 June 2015, Belgrade, Serbia)
This document provides a summary of the work of the WHO Regional Office for Europe. It discusses progress made in several areas such as:
1) Declining inequalities in life expectancy across countries in the region.
2) Strengthening of policies by European countries to reduce tobacco and alcohol consumption and increase physical activity.
3) Successful control and prevention programs reducing communicable diseases like tuberculosis, measles, and malaria.
4) Efforts to strengthen health systems, promote universal health coverage, and develop a people-centered approach to healthcare delivery.
5) Work to improve emergency preparedness, surveillance of diseases, and response capacity to health emergencies and public health threats.
The document summarizes the WHO European Action Plan for the Prevention and Control of Noncommunicable Diseases 2016–2025. The plan aims to achieve reductions in premature mortality from noncommunicable diseases like cardiovascular disease, cancer, diabetes and chronic respiratory diseases. It outlines priority areas like governance, surveillance, prevention, health systems strengthening, and population-level policies. The plan is aligned with the global action plans and frameworks to address noncommunicable diseases.
This document proposes a global hepatitis strategy to control and prevent viral hepatitis. It summarizes that hepatitis is a silent epidemic with a high death toll but low awareness. The strategy proposes impact targets by 2030 of reducing new chronic hepatitis B and C cases by 90% and reducing hepatitis deaths by 65%. It outlines key effective interventions such as hepatitis B vaccination, safe injection practices, harm reduction, and treatment. The proposed way forward is a regional action plan for WHO and tailored country actions based on disease burden analysis and focus on efficient investments.
Presented at the 66th session of the WHO Regional Committee for Europe by:
Dr Oleg Chestnov, Assistant Director-General, WHO
Dr Jill Farrington, Acting Head, NCD Project Office, Moscow
Dr Gauden Galea, Director, Noncommunicable Diseases and
Promoting Health through the Life-course, WHO/Europe
Presentación de David Novillo en el nternational Workshop RITMOS, celebrado el pasado 14 y 15 de octubre en Barcelona con el apoyo de la UOC y Mobile World Capital de Barcelona (MWBC)
Presentation delivered by Claudia Stein, Director, Division of Information, Evidence, Research and Innovation, on 15 September 2015, at the 65th session of the WHO Regional Committee for Europe (Vilnius, Lithuania, 14–17 September 2015)
Similar to Implementation of the United Nations Political Declaration on Prevention and Control of Noncommunicable Diseases (20)
This document provides an introduction and overview of implementing Vision 2023 in the Eastern Mediterranean Region. It includes progress updates on SDG 3 targets and coverage of critical interventions. Charts and data are presented on physician density, disease elimination, immunization coverage, and humanitarian needs in the region from 2000 to 2023.
The document summarizes the development process and timeline for the 14th WHO General Programme of Work (GPW 14) covering 2025-2028. It outlines the rationale for a new global health strategy given a dramatically changing world. The goal is to promote, provide, and protect health for all. Six strategic objectives are proposed to achieve this: achieve transformative action on climate and health; ensure health is central to policies driving determinants; address inequities in essential health services and interventions; reverse trends in catastrophic health spending; rapidly respond to acute crises and ensure essential services in protracted crises; and ensure all countries are prepared to prevent and mitigate health risks. The next steps outlined are to define WHO's major cross
The document summarizes updates on WHO's regional transformation efforts. It discusses the creation of an Action for Results Group to develop a regional action plan focused on empowering country offices. This includes ensuring effective ways of working, sufficient resources and capacities, and delegation of authority. Major results include developing cooperation strategies between countries and accelerating working groups. Next steps are continuing implementation to drive impact, scaling capacities, engaging member states, and strengthening WHO's leadership role.
The document summarizes the agenda items for the 154th session of the WHO Executive Board to be held from 22 January to 27 February 2024. It will address 26 agenda items under the four pillars of the GPW13: (1) universal health coverage, (2) health emergencies, (3) health and well-being, and (4) effective and efficient WHO support to countries. It also lists additional agenda items proposed by Iraq, Morocco, Qatar, and Somalia. The session will be held in-person in Geneva and will include adoption of the agenda, reports from the Director-General and regional committees, and matters relating to budgets, management, and future World Health Assembly sessions.
Resolutions and decisions of regional interest adopted by the Seventy-sixth World Health Assembly and the Executive Board at its 152nd and 153rd sessions
The document discusses WHO's proposed approach for its first Investment Round in late 2024. It notes that the Investment Round is a key step in WHO's transformation towards sustainable financing. It provides a timeline of recent events leading up to the Investment Round, including the approval of a new resource mobilization strategy and decisions by the World Health Assembly and Executive Board. It outlines objectives for the Investment Round such as improving WHO's sustainable financing, broadening its donor base, and increasing fundraising efficiency. The document proposes a roadmap and approach for planning the Investment Round that emphasizes co-creation with Member States and bringing together global health partners to rally support around WHO's 14th General Programme of Work and turn the tide on achieving SDG 3 of ensuring
This document proposes a collaborative, integrated approach to preventing, controlling, and eliminating vector-borne diseases in the Eastern Mediterranean region. It notes the increasing burden of these diseases, driven by factors like climate change, conflict, and urbanization. It advocates addressing the three main vector-borne disease groups - caused by Anopheles, Aedes, and other vectors - together rather than separately. This integrated approach would leverage existing programmatic strengths while consolidating resources for more efficient and effective surveillance, control, and response efforts against all vector-borne diseases in the region.
The document discusses WHO's proposed approach for its first Investment Round in late 2024. It notes that the Investment Round is a key step in WHO's transformation towards sustainable financing. It provides a timeline of recent events leading up to the Investment Round, including the approval of a new resource mobilization strategy and decisions by the World Health Assembly and Executive Board. It outlines objectives for the Investment Round such as improving WHO's sustainable financing, broadening its donor base, and increasing fundraising efficiency. The document proposes a roadmap and approach for planning the Investment Round that emphasizes co-creation with Member States and bringing together global health partners to rally support around WHO's 14th General Programme of Work and turn the tide on achieving SDG 3 of ensuring
The document proposes a new regional framework for action on climate change, health, and the environment from 2023-2029. The previous framework from 2017-2021 had unfinished goals. If adopted, the new framework would help countries implement the WHO COP26 Health Programme and build on other recent regional initiatives. It outlines objectives like building climate-resilient health systems and prioritizing health in climate policies. Targeted changes include integrating health into climate negotiations and developing evidence on the health impacts of climate mitigation and adaptation. The framework provides examples of strategic country actions and requests that member states designate focal points, implement plans of action, and commit resources to strengthen climate resilience in health systems.
The document discusses the health workforce challenges in the Eastern Mediterranean region. It notes that 90% of countries faced disruptions to essential health services due to COVID-19, with 66% attributing the disruptions to health workforce issues. The region will face a shortage of over 2 million health workers by 2030. It outlines strategic objectives and calls for accelerated action to enhance and scale up a fit-for-purpose health workforce through mobilizing investments, transforming education, strengthening primary care and emergency response capabilities, and addressing issues like international mobility and retention.
This document discusses strengthening public health readiness for mass gatherings in the Eastern Mediterranean Region. It begins by defining mass gatherings and the obligations under the International Health Regulations. It then outlines some of the public health threats that can arise from mass gatherings, including infectious diseases, non-communicable diseases, injuries, and psychological impacts. However, it also notes that mass gatherings can create opportunities to enhance health systems and increase disease prevention awareness. The document discusses examples of WHO's support for mass gatherings in the region. It proposes a regional framework to guide countries in establishing arrangements and capacities to safely host mass gatherings. The framework focuses on risk assessment, health system strengthening, multisectoral coordination, partnerships, planning, and
This document proposes a regional framework for addressing noncommunicable diseases (NCDs) in emergencies. It notes that almost half of countries in the region face emergencies like conflicts, natural disasters, or financial crises. People with NCDs are more vulnerable during emergencies due to disrupted health services, competing priorities, and insecurity. The framework establishes guidelines for integrating NCD care into emergency response, including continuity of services through emergency kits, and adapting delivery models across preparedness, response, and recovery phases. It calls on member states to invest in NCDs and strengthen data collection, and for WHO to support NCD integration and partnerships. The overall aim is to balance priorities and ensure NCD care
This document discusses efforts to end polio transmission by the end of 2023. It summarizes the status of wild poliovirus and vaccine-derived poliovirus outbreaks in various countries. While the goal of stopping wild poliovirus transmission in Afghanistan and Pakistan by mid-2024 is now considered "off track", interruption of transmission is still possible within the next six months. However, stopping global transmission of circulating vaccine-derived poliovirus type 2 will likely be missed. The document requests that regional and national commitments be sustained to stop endemic polio and help chart a pathway to protect children in Yemen.
This document discusses emergency response challenges and opportunities in the Eastern Mediterranean region. It notes that the number of people in need of humanitarian assistance has increased 117-110% since 2015 and outlines the top countries burdened by fragility, conflict, and refugee crises. While COVID-19 response increased some capacities, preparedness remains a challenge. The document highlights some response successes but also areas needing improvement like operational readiness and fragmentation. It concludes by emphasizing opportunities to sustain COVID gains through resilience-building, and priorities around preparedness, high-threat pathogens, protracted crises, and supply chain management.
This document discusses the importance of national clinical practice guideline programs. It notes that while evidence-based medicine has been emphasized since the 1990s, 70% of countries in the WHO Eastern Mediterranean Region still lack formal guideline development and implementation programs. The document outlines the benefits of national programs, including increasing quality of care, efficiency, and health outcomes. It also analyzes challenges faced by many countries, such as limited resources and capacity. The document describes WHO initiatives to support countries in establishing their own programs, using Egypt as an example. It emphasizes the need for high-level commitment, stakeholder engagement, and expanded national capacities to effectively develop and implement evidence-informed clinical guidelines.
This document discusses the public health burden of trauma in humanitarian emergencies in the Eastern Mediterranean Region (EMR). It notes that many countries in the region experience conflicts, violence, natural disasters and fragile situations that result in trauma. Trauma outcomes are often worse in low-income countries due to limited pre-hospital and hospital trauma care services. The document proposes a regional initiative to minimize trauma morbidity and mortality through coordinated leadership, workforce training programs, and support to priority fragile countries to strengthen pre-hospital services, train hospital staff in mass casualty management, and develop accredited trauma training courses. It provides some examples of initial progress made through this initiative.
This document proposes a regional approach to minimizing trauma-related morbidity and mortality in humanitarian emergencies. It notes the high public health burden of trauma in conflict-affected countries in the region like Afghanistan, Iraq, Syria, and Yemen. Prehospital care is limited, over 60% of trauma deaths occur before reaching the hospital, and fatality rates are triple those in high-income countries. The proposal calls for member states to support a Regional Trauma Initiative that coordinates partners, invests in prehospital care and the health care workforce through dedicated training programs, and utilizes regional expertise to build emergency care systems and support fragile contexts.
Resolutions and decisions of regional interest adopted by the Seventy-fifth World Health Assembly and the Executive Board at its 150th and 151st sessions
More from WHO Regional Office for the Eastern Mediterranean (20)
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)GeorgeKieling1
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
- Video recording of this lecture in English language: https://youtu.be/RvdYsTzgQq8
- Video recording of this lecture in Arabic language: https://youtu.be/ECILGWtgZko
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...Donc Test
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient.
One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells.
Safe methods have been devised to do this, using several viral and non-viral vectors.
In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The biggest hurdle faced by medical research in gene therapy is the availability of effective gene-carrying vectors that meet all of the following criteria:
Protection of transgene or genetic cargo from degradative action of systemic and endonucleases,
Delivery of genetic material to the target site, i.e., either cell cytoplasm or nucleus,
Low potential of triggering unwanted immune responses or genotoxicity,
Economical and feasible availability for patients .
Viruses are naturally evolved vehicles that efficiently transfer their genes into host cells.
Choice of viral vector is dependent on gene transfer efficiency, capacity to carry foreign genes, toxicity, stability, immune responses towards viral antigens and potential viral recombination.
There are a wide variety of vectors used to deliver DNA or oligo nucleotides into mammalian cells, either in vitro or in vivo.
The most common vector system based on retroviruses, adenoviruses, herpes simplex viruses, adeno associated viruses.
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Congestive Heart failure is caused by low cardiac output and high sympathetic discharge. Diuretics reduce preload, ACE inhibitors lower afterload, beta blockers reduce sympathetic activity, and digitalis has inotropic effects. Newer medications target vasodilation and myosin activation to improve heart efficiency while lowering energy requirements. Combination therapy, following an assessment of cardiac function and volume status, is the most effective strategy to heart failure care.
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Implementation of the United Nations Political Declaration on Prevention and Control of Noncommunicable Diseases
1. Implementation of the United
Nations Political Declaration
on Prevention and Control of
Noncommunicable Diseases
Agenda item 2(d)
62nd Session of the Regional Committee for the Eastern Mediterranean
58 October 2015
1
2. 1.Commitments
• The global commitments
• The regional road map
2. How we
measure
progress
• Reporting on regional and
national progress
3. Country
response
• Where do we stand
Outline
Implementation of the United Nations Political Declaration on
Prevention and Control of Noncommunicable Diseases 2
4. By 2015
Set national noncommunicable disease targets for 2025 or
2030 and monitor results
Develop a national multisectoral
action plan
By 2016
Implement the "best buy"
interventions to reduce risk factors
Implement the "best buy" interventions to strengthen health
systems to address noncommunicable diseases
2014 United Nations outcome document (A/RES/68/300)
Implementation of the United Nations Political Declaration on
Prevention and Control of Noncommunicable Diseases 4
5. 1
2
3
4
National targets and indicators
Mortality data
Risk factor surveys
National integrated strategy/action plan
5 Tobacco demand-reduction measure
10 progress monitoring indicators
Implementation of the United Nations Political Declaration on
Prevention and Control of Noncommunicable Diseases 5
6. 6
7
8
9
10
Harmful use of alcohol reduction measures
Unhealthy diet reduction measures
Public awareness on diet/physical activity
Guidelines for the management of major
noncommunicable diseases
Drug therapy/counselling for high-risk persons
10 progress monitoring indicators
Implementation of the United Nations Political Declaration on
Prevention and Control of Noncommunicable Diseases 6
7. Framework for Action to
implement the United Nations
Political Declaration
Implementation of the United Nations Political Declaration on
Prevention and Control of Noncommunicable Diseases 7
8. Implementation status in the area of
governance, surveillance and health care
(1)
• Governance
– 32% (7 countries) developed an operational national
multisectoral policy/action plan
– 18% (4 countries) set targets for 2025 based on WHO
guidance
• Surveillance, monitoring and evaluation
– 22% (5 countries) Have satisfactory functioning system for
generating reliable cause-specific mortality data on a routine
basis
– 36% (8 countries) Have implemented a STEPS survey or a
comprehensive health examination survey within the past 5
years
Implementation of the United Nations Political Declaration on
Prevention and Control of Noncommunicable Diseases 8
9. Implementation status in the area of
governance, surveillance and health care
(2)
• Health care
– 73% (16 countries) Have national guidelines/protocols
available for cardiovascular disease and diabetes mellitus
in primary health care
– 50% (11 countries) Have 7 essential medicines required
to treat eligible people at high risk of cardiovascular
disease in the national primary health care package
Implementation of the United Nations Political Declaration on
Prevention and Control of Noncommunicable Diseases 9
10. 27% (6) 27% (6)
13% (3) 13% (3)
27% (6)
9% (2)
0%
10%
20%
30%
40%
50%
Monitor
tobacco use
Protect
people from
tobacco
smoke
Offer help to
quit tobacco
use
Warn about
the dangers
of tobacco
Enforce bans
on tobacco
advertising,
promotion
and
sponsorship
Raise taxes
Implementation status of tobacco
control highest MPOWER measures
Implementation of the United Nations Political Declaration on
Prevention and Control of Noncommunicable Diseases 10
11. Implementation status of the diet and
physical activity related “best buys”
36%(9)
22% (5)
72% (17)
36% (8)
0%
10%
20%
30%
40%
50%
60%
70%
80%
Reduce salt Eliminate
industrially
produced trans-fat
Implement the
International Code
of Marketing of
Breast-milk
Substitutes
Conduct at least
one campaign to
promote physical
activity
Implementation of the United Nations Political Declaration on
Prevention and Control of Noncommunicable Diseases 11
12. Conclusions and the way
forward
Significant additional investments are required to address
noncommunicable diseases in the post-2015 era:
• Prevention: “best buys” in the areas of tobacco control,
physical activity, healthy diet and avoiding harmful use
of alcohol
• Surveillance: focusing on outcomes, exposures and
health system capacity and response
• Management: critical to achieving the global target to
reduce premature mortality by 25% in 2025
Implementation of the United Nations Political Declaration on
Prevention and Control of Noncommunicable Diseases 12
Governance:
Developed an operational national multisectoral policy/action plan
Bahrain, Iraq, Kuwait, Morocco, Qatar, Saudi Arabia and Sudan
Set targets for 2025 based on WHO guidance
Kuwait, Morocco, Qatar, Sudan
Surveillance
Have satisfactory functioning system for generating reliable cause-specific mortality data on a routine basis
Bahrain, Jordan, Kuwait, Qatar and United Arab Emirates
Have implemented a STEPS survey or a comprehensive health examination survey within last 5 years
Egypt, Iran, Kuwait, Lebanon, Pakistan, Palestine, Saudi Arabia, and Qatar
Have a national or subnational operational population-based cancer registry
Bahrain, Egypt, Iran, Jordan, Morocco, Lebanon, Kuwait, Saudi Arabia, Qatar, Oman, Sudan, Tunisia, and United Arab Emirates.
Health Care:
Have national guidelines / protocols available for CVD and DM in PHC
Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Morocco, Oman, Palestine, Qatar, Saudi Arabia, Sudan, Syria, Tunisia, UAE and Yemen
Have 7 essential medicines required to treat eligible people at high risk of CVD in the national essential primary health care package
Bahrain, Egypt, Iran, Jordan, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Sudan and Syria
Governance:
Developed an operational national multisectoral policy/action plan
Bahrain, Iraq, Kuwait, Morocco, Qatar, Saudi Arabia and Sudan
Set targets for 2025 based on WHO guidance
Kuwait, Morocco, Qatar, Sudan
Surveillance
Have satisfactory functioning system for generating reliable cause-specific mortality data on a routine basis
Bahrain, Jordan, Kuwait, Qatar and United Arab Emirates
Have implemented a STEPS survey or a comprehensive health examination survey within last 5 years
Egypt, Iran, Kuwait, Lebanon, Pakistan, Palestine, Saudi Arabia, and Qatar
Have a national or subnational operational population-based cancer registry
Bahrain, Egypt, Iran, Jordan, Morocco, Lebanon, Kuwait, Saudi Arabia, Qatar, Oman, Sudan, Tunisia, and United Arab Emirates.
Health Care:
Have national guidelines / protocols available for CVD and DM in PHC
Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Morocco, Oman, Palestine, Qatar, Saudi Arabia, Sudan, Syria, Tunisia, UAE and Yemen
Have 7 essential medicines required to treat eligible people at high risk of CVD in the national essential primary health care package
Bahrain, Egypt, Iran, Jordan, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Sudan and Syria
Nutrition:
Applied measures to reduce salt in at least one highly consumed food item
Bahrain, Iran, Kuwait, Lebanon, Oman, Qatar, Tunisia, UAE, Morocco
Applied regulatory measures to eliminate industrially produced trans-fat in the food supply and to replace saturated fatty acids with polyunsaturated fatty acids in food products
Egypt, Iran, Iraq, Kuwait and Qatar
Applied legislation/regulation implementing the International Code for Marketing of Breast-milk Substitutes
Afghanistan, Bahrain, Djibouti, Egypt, Jordan, Iran, Kuwait, Lebanon, Oman, Palestine, Pakistan, Saudi Arabia, Sudan, Syria, Tunisia and Yemen
Physical activity
Have conducted at least one campaign (short event) to promote physical activity
Bahrain, Iran, Iraq, Kuwait, Morocco, Oman, Qatar and UAE